White matter disorders and cerebral calcification - narrow panel
Gene: ERCC4EnsemblGeneIds (GRCh38): ENSG00000175595
EnsemblGeneIds (GRCh37): ENSG00000175595
OMIM: 133520, Gene2Phenotype
ERCC4 is in 24 panels
3 reviews
Sarah Leigh (Genomics England Curator)
The rating of this gene has been updated to Amber following NHS Genomic Medicine Service approval.Created: 30 Jan 2023, 4:26 p.m. | Last Modified: 30 Jan 2023, 4:26 p.m.
Panel Version: 2.9
Eleanor Williams (Genomics England Curator)
Comment on list classification: Leaving as green for now, but with a recommendation for an amber rating following GMS review. One case where white matter lesions are reported as part of a broader phenotype and 2 cases with milder phenotypes related to white matter.Created: 11 May 2021, 1:59 p.m. | Last Modified: 11 May 2021, 1:59 p.m.
Panel Version: 1.83
Associated with Xeroderma pigmentosum, type F/Cockayne syndrome #278760, Fanconi anemia, complementation group Q #615272 and XFE progeroid syndrome #610965 in OMIM.
ERCC4 is also known as XPF
Focussed on the reports of patients with Xeroderma pigmentosum, type F/Cockayne syndrome and XFE progeroid syndrome rather than the cancer phenotype of Fanconi anemia. Some evidence of white matter changes but not a prominent feature.
PMID: 23623389 - Kashiyama et al 2013 - report 2 unrelated individuals with Cockayne syndrome and variants identified in ERCC4. For patient CS1USAU there were no obvious brain abnormalities apart from some delayed myelination on brain MRI at the age of 3 years, although basal ganglia T1 shortening was observed at the age of 7 years. For patient XPCS1CD MRI of the brain showed increased signal in the peritrigonal white-matter bilaterally.
PMID: 29105242 - Mori et al 2018 - carried out sequencing for 42 unsolved cases submitted to the International Registry of Werner Syndrome and found two patients with variants in ERCC4. One patient, CALIF1010 was presented at age 35 for evaluation of microcephaly, enophthalmos and a prematurely aged appearance. A brain MRI confirmed enophthalmos, brain abnormalities, including white matter lesions. She was found to be compound heterozygous for variants in ERCC4 (parental DNA unvailable). No brain abnormalities were reported in the other patient.Created: 11 May 2021, 1:57 p.m. | Last Modified: 11 May 2021, 1:57 p.m.
Panel Version: 1.82
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Xeroderma pigmentosum, type F/Cockayne syndrome, OMIM:278760; XFE progeroid syndrome, OMIM:610965
Publications
Zornitza Stark (Australian Genomics)
Cannot find specific reports of white matter abnormalities/leukodystrophy associated with variants in this gene.Created: 15 Sep 2020, 10:21 a.m. | Last Modified: 15 Sep 2020, 10:21 a.m.
Panel Version: 1.14
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Xeroderma pigmentosum, group F, MIM# 278760
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- NHS GMS
- Expert Review Amber
- Phenotypes
-
- Xeroderma pigmentosum, type F/Cockayne syndrome, OMIM:278760
- XFE progeroid syndrome, OMIM:610965
- OMIM
- 133520
- Clinvar variants
- Variants in ERCC4
- Penetrance
- None
- Publications
- Panels with this gene
-
- Structural eye disease
- Monogenic hearing loss
- Fetal anomalies
- Severe microcephaly
- White matter disorders and cerebral calcification - narrow panel
- Childhood solid tumours cancer susceptibility
- Anophthalmia or microphthalmia
- Radial dysplasia
- Intellectual disability
- Cytopenias and congenital anaemias
- Limb disorders
- Xeroderma pigmentosum, Trichothiodystrophy or Cockayne syndrome
- Primary immunodeficiency or monogenic inflammatory bowel disease
- DDG2P
- Haematological malignancies cancer susceptibility
- Pigmentary skin disorders
- Monogenic short stature
- COVID-19 research
- Neurofibromatosis Type 1
- Haematological malignancies for rare disease
- Hereditary ataxia with onset in adulthood
- Confirmed Fanconi anaemia or Bloom syndrome
- Childhood solid tumours
- Adult solid tumours cancer susceptibility
History Filter Activity
Removed Tag
Sarah Leigh (Genomics England Curator)Tag Q2_21_rating was removed from gene: ERCC4.
Added New Source, Added New Source, Status Update
Sarah Leigh (Genomics England Curator)Source Expert Review Amber was added to ERCC4. Source NHS GMS was added to ERCC4. Rating Changed from Green List (high evidence) to Amber List (moderate evidence)
Added Tag
Eleanor Williams (Genomics England Curator)Tag Q2_21_rating tag was added to gene: ERCC4.
Set Phenotypes
Eleanor Williams (Genomics England Curator)Phenotypes for gene: ERCC4 were changed from Xeroderma pigmentosum, type F/Cockayne syndrome, 278760; Xeroderma pigmentosum, group F, 278760 to Xeroderma pigmentosum, type F/Cockayne syndrome, OMIM:278760; XFE progeroid syndrome, OMIM:610965
Set publications
Eleanor Williams (Genomics England Curator)Publications for gene: ERCC4 were set to
Entity classified by Genomics England curator
Eleanor Williams (Genomics England Curator)Gene: ercc4 has been classified as Green List (High Evidence).
Panel promoted to version 1.0
Louise Daugherty (Genomics England Curator)Checked against super panel made up of the panel constituents. Ready to promote to version 1
Created, Added New Source, Set mode of inheritance, Set Phenotypes
Ellen McDonagh (Genomics England Curator)gene: ERCC4 was added gene: ERCC4 was added to White matter disorders and cerebral calcification - narrow panel. Sources: Expert Review Green Mode of inheritance for gene: ERCC4 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: ERCC4 were set to Xeroderma pigmentosum, type F/Cockayne syndrome, 278760; Xeroderma pigmentosum, group F, 278760